[
  {
    "ts": null,
    "headline": "Why Organon Is A Top Pick For Income Investors",
    "summary": "In mid-Feb., Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for income-oriented investors.",
    "url": "https://finnhub.io/api/news?id=697fea97f771736843602e4ccd567ee09566458d477be611dbdde99159b46b96",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742252303,
      "headline": "Why Organon Is A Top Pick For Income Investors",
      "id": 133211092,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1472143072/image_1472143072.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "In mid-Feb., Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for income-oriented investors.",
      "url": "https://finnhub.io/api/news?id=697fea97f771736843602e4ccd567ee09566458d477be611dbdde99159b46b96"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=c0ec8b12ad5db73cbfea019c83b29597c68ce19edebab4f42d356c2b5d54b21f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742229060,
      "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "id": 133213725,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=c0ec8b12ad5db73cbfea019c83b29597c68ce19edebab4f42d356c2b5d54b21f"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie - ELAHERE Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients",
    "summary": "NORTH CHICAGO - AbbVie today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE in women with folate receptor alpha -positive...",
    "url": "https://finnhub.io/api/news?id=f3e09097f76a0ee2f5a5ebb7ff1d1de54223172d7fb5b8eca6fd4418ba03ddd2",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742210291,
      "headline": "AbbVie - ELAHERE Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients",
      "id": 133207810,
      "image": "",
      "related": "ABBV",
      "source": "Finnhub",
      "summary": "NORTH CHICAGO - AbbVie today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE in women with folate receptor alpha -positive...",
      "url": "https://finnhub.io/api/news?id=f3e09097f76a0ee2f5a5ebb7ff1d1de54223172d7fb5b8eca6fd4418ba03ddd2"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie reports final analysis from Phase III trial of Elahere for ovarian cancer",
    "summary": "The trial involved 453 subjects with high-grade serous epithelial platinum-resistant ovarian cancer.",
    "url": "https://finnhub.io/api/news?id=d6f2533092163a586552db28fe1a0a992e07d1a6b94a66a09e7ca66c77f22574",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742207191,
      "headline": "AbbVie reports final analysis from Phase III trial of Elahere for ovarian cancer",
      "id": 133324572,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The trial involved 453 subjects with high-grade serous epithelial platinum-resistant ovarian cancer.",
      "url": "https://finnhub.io/api/news?id=d6f2533092163a586552db28fe1a0a992e07d1a6b94a66a09e7ca66c77f22574"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands",
    "summary": "AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands are included in this Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=2c6054d6b8915dd589edf7d68fac991b7a0e58c99246fdb18674a32dacf6b159",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742205960,
      "headline": "The Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands",
      "id": 133324573,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands are included in this Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=2c6054d6b8915dd589edf7d68fac991b7a0e58c99246fdb18674a32dacf6b159"
    }
  }
]